share_log

4: Statement of changes in beneficial ownership of securities-Officer WORLAND STEPHEN T

SEC ·  May 18 04:03

Summary by Futu AI

On May 15, 2024, Stephen T. Worland, the Chief Executive Officer of eFFECTOR Therapeutics, Inc. (EFTR), completed a purchase of 1,806 shares of common stock at a price of $1.683 per share. Following this transaction, Worland's direct holdings in the company increased to 12,494 shares. The transaction is classified as a grant, award, or other acquisition, according to the transaction code description. In addition to his direct holdings, Worland also has an indirect beneficial ownership of 22,493 shares through a trust.
On May 15, 2024, Stephen T. Worland, the Chief Executive Officer of eFFECTOR Therapeutics, Inc. (EFTR), completed a purchase of 1,806 shares of common stock at a price of $1.683 per share. Following this transaction, Worland's direct holdings in the company increased to 12,494 shares. The transaction is classified as a grant, award, or other acquisition, according to the transaction code description. In addition to his direct holdings, Worland also has an indirect beneficial ownership of 22,493 shares through a trust.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated